Menotropins
Composition
Contains Menotropins, a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) extracted from the urine of postmenopausal women.
Indications
Used to stimulate follicular development in women undergoing assisted reproductive technologies (ART) like IVF and to treat infertility due to anovulation.
Side effects
Ovarian hyperstimulation syndrome (OHSS), injection site reactions, headache, abdominal pain, nausea.
Precautions
Monitor ovarian response closely to prevent OHSS; use cautiously in patients with ovarian cysts or hormone-sensitive tumors.
Contraindications
Primary ovarian failure, ovarian cysts unrelated to infertility, uncontrolled thyroid or adrenal dysfunction, hypersensitivity to menotropins.
Dosage and administration
Typically 75–150 IU daily by intramuscular (IM) or subcutaneous (SC) injection, adjusted based on ovarian response.
Countries
Available Forms
Injectable powder for reconstitution (usually in 75 IU or 150 IU vials).